- ►diabetesjournals.org A Ferrara, AJ Karter, LM Ackerson, JY Liu, JV … - Diabetes care, 2001 - Am Diabetes Assoc RESULTS—The mean age was 64.7 years (SD ± 8.7). The study cohort comprised
55% non-Hispanic whites, 14% non-Hispanic blacks, 12% Hispanics, 11% Asians, 4%
“other” ethnic groups, and 4% with missing ethnicity data. Current HRT ... Cited by 53 - Related articles - BL Direct - All 6 versions
- ►endojournals.org KE Friday, C Dong, RU Fontenot - Journal of Clinical Endocrinology & Metabolism, 2001 - Endocrine Soc When compared with 8 weeks of placebo, estrogen reduced fasting serum glucose
(7.2 ± 0.3 vs. 8.4 ± 0.4 mmol/L, P = 0.0003), glycated hemoglobin (8.7 ± 0.4%
vs. 9.3 ± 0.4%, P = 0.04), total cholesterol (5.27 ± 0.20 vs. 5.50 ± ... Cited by 60 - Related articles - BL Direct - All 6 versions
PJ Manning, A Allum, S Jones, WHF … - Archives of Internal Medicine, 2001 - archinte.highwire.org Background Postmenopausal women with diabetes are at high risk for
cardiovascular disease, compared with their nondiabetic counterparts. Combined
continuous hormone replacement therapy (HRT) is associated with ... Cited by 46 - Related articles - BL Direct - All 5 versions
- Free from Publisher CJ Crespo, E Smit, A Snelling, CT Sempos, … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Our results show that postmenopausal women with diabetes had increased
dyslipidemia compared with nondiabetic women. Among diabetic women, current
users of HRT had significant different lipid and glucose control levels ... Cited by 30 - Related articles - BL Direct - All 8 versions
- ►endojournals.org M Perera, N Sattar, JR Petrie, C Hillier, M … - Journal of Clinical Endocrinology & Metabolism, 2001 - Endocrine Soc People with type 2 diabetes have a substantially increased risk of coronary
heart disease (CHD). Short-term studies with unopposed oral estradiol in women
with diabetes have suggested potentially beneficial effects on lipids, ... Cited by 55 - Related articles - BL Direct - All 11 versions
- ►diabetesjournals.org [PDF] K Samaras, CS Hayward, D Sullivan, RP … - Diabetes Care, 1999 - Am Diabetes Assoc Central abdominal obesity re lates st rongly to insulin resistance (1,2) and p
redicts the development of type 2 diabetes (3) and cardiovascular disease (4) in
women. The menopause is associated with increases in central abdominal ... Cited by 75 - Related articles - BL Direct - All 6 versions
RJ TROISI, CC Cowie, MI Harris - Obstetrics & Gynecology, 2000 - journals.lww.com Cited Here...: Cross-sectional data from the third National Health and Nutrition
Examination Survey (1988-1994) included levels of hemoglobin A 1c in women with
diagnosed diabetes and levels of hemoglobin A 1c , fasting and 2-hour ... Cited by 35 - Related articles - BL Direct - All 4 versions
- ►endojournals.org B Andersson, LA Mattsson, L Hahn, L Lapidus … - Journal of Clinical Endocrinology & Metabolism, 1997 - Endocrine Soc Hyperandrogenicity in women is closely associated with insulin resistance and a
risk factor for cardiovascular disease and noninsulin-dependent diabetes
mellitus (NIDDM). Therefore, 25 postmenopausal women with NIDDM and sex ... Cited by 156 - Related articles - BL Direct - All 5 versions
DB Petitti, S Sidney, CP Quesenberry Jr - Epidemiology, 2000 - jstor.org Page 1. Hormone Replacement Therapy and the Risk of Myocardial Infarction
in Women with Coronary Risk Factors Diana B. Petitti,1 ... Cited by 11 - Related articles - BL Direct - All 4 versions
- ►adisonline.com [PDF] SE Fineberg - Drugs &# 38; Aging, 2000 - ingentaconnect.com Abstract Despite evidence that supports the beneficial effects of postmenopausal
hor- mone replacement therapy (HRT), concerns remain about its possible adverse
effects. However, entry into the postmenopausal state is associated with ... Cited by 25 - Related articles - BL Direct - All 6 versions
